NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-NS-20-077 from the NIH Guide for Grants and Contracts
Notice NOT-NS-20-076 from the NIH Guide for Grants and Contracts
Notice NOT-MH-20-065 from the NIH Guide for Grants and Contracts
Notice NOT-AG-20-035 from the NIH Guide for Grants and Contracts
Notice NOT-EB-20-010 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-140 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DE-21-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research to test causal mechanisms underlying the etiology or prevention of dental fear, anxiety, or phobia.
Funding Opportunity PAR-20-244 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide opportunities for eligible small business concerns (SBCs) to submit NIH Small Business Innovation Research (SBIR) grant applications to develop interactive digital media science, technology, engineering and mathematics (STEM) resources that address student career choice and health and medicine topics for: (1) pre-kindergarten to grade 12 (P-12) students, and pre- and in-service teachers and famlies ("Teachers") or (2) Informal science education (ISE), i.e., outside the classroom resources for the general public. Interactive digital media (IDM) are defined as products and services on digital computer-based systems which respond to the user's actions by presenting content such as text, moving image, animation, video, audio, and video games. There is a large body of evidence that IDM technology has the potential to support learning in a variety of contexts from primary and secondary schools, to universities, adult education and workplace training. IDM is widely used to train, educate, and encourage behavioral changes in a virtual world format where progressive learning, feedback on success and user control are combined into an interactive and engaging experience. It is anticipated that this SBIR FOA will facilitate the translation of new or existing health and medicine-based, P-12 STEM curricula and museum exhibits into educational Interactive Digital Media STEM (IDM STEM) resources that will provide a hands-on, inquiry-based and learning-by-doing experience for students, teachers and the community.
Funding Opportunity PAR-20-239 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide opportunities for eligible small business concerns (SBCs) to submit NIH Small Business Innovation Research (SBIR) grant applications to develop interactive digital media science, technology, engineering and mathematics (STEM) resources that address student career choice and health and medicine topics for: (1) pre-kindergarten to grade 12 (P-12) students and pre- and in-service teachers and famlies or (2) Informal science education (ISE), i.e., outside the classroom resources for the general public. Interactive digital media (IDM) are defined as products and services on digital computer-based systems which respond to the user's actions by presenting content such as text, moving image, animation, video, audio, and video games. There is a large body of evidence that IDM technology has the potential to support learning in a variety of contexts from primary and secondary schools, to universities, adult education and workplace training. IDM is widely used to train, educate, and encourage behavioral changes in a virtual world format where progressive learning, feedback on success and user control are combined into an interactive and engaging experience. It is anticipated that this SBIR FOA will facilitate the translation of new or existing health and medicine-based, P-12 STEM curricula and museum exhibits into educational Interactive Digital Media STEM (IDM STEM) resources that will provide a hands-on, inquiry-based and learning-by-doing experience for students, teachers and the community.
Funding Opportunity PAR-20-243 from the NIH Guide for Grants and Contracts. This funding opportunity announcement aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.
Funding Opportunity RFA-CA-20-042 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) as a part of its Beau Biden Cancer Moonshot Initiative invites submission of applications requesting support for projects that will accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP) as Recommendation I: Generation of Human Tumor Atlases. The overarching goal of this FOA is to accelerate research efforts conducted and led by the Human Tumor Atlas Network (HTAN, humantumoratlas.org) via the implementation of three-dimensional (3D) imaging technologies that will allow for a comprehensive view of the dynamic multidimensional ecosystems that define tumors in humans. Each project will lead to the multiplexed 3D characterization of at least one cancer transition investigated by the HTAN (pre-malignant to malignant, primary to metastatic, therapy responsive to resistant). The data and analytical tools generated through this FOA will be made available for use by the research and clinical communities through the activities of the HTAN Data Coordinating Center.
Funding Opportunity RFA-AG-21-026 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) utilizes the SBIR cooperative agreement (U44) activity code to support the preclinical development of emerging therapeutics targeting fundamental mechanisms of aging (e.g., inflammation, cell senescence, proteostasis). This includes the translation of a broad range of potential geroscience-based therapies, such as new classes of compounds (e.g., senolytics), biologics, stem/progenitor cell-based therapies, repositioning of existing investigational drugs, and repurposing of Food and Drug Administration (FDA)-approved drugs for the treatment and prevention of clinical conditions related to aging and common in the aged. Examples of translational research activities eligible under this FOA include target validation, optimization of lead compounds, pharmacokinetics and drug disposition studies, as well as preclinical safety/toxicology studies.
Notice NOT-DE-20-028 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-129 from the NIH Guide for Grants and Contracts
Notice NOT-CA-20-077 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-240 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NINDS Neuroscience Development for Advancing the Careers of a Diverse Research Workforce R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce by (1) increasing the pool of current and future Ph.D.-level research scientists from diverse backgrounds underrepresented in biomedical neuroscience research; and (2) facilitating the career advancement/transition of the participants to the next step of their neuroscience careers. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on NINDS relevant research experiences, mentoring activities that enhance compentencies or leadership education and courses on skills development. Programs that target transitions and/or more than one career stage for neuroscience career advancement and progression are strongly encouraged. NINDS support for this R25 program relies equally on scientific merit and programmatic considerations. Consequently, we recommend that potential applicants contact Scientific/Research staff at NINDS before preparing an application. NINDS will not support projects if they do not fulfill current programmatic priorities at NINDS.
Funding Opportunity RFA-AA-20-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U54 applications for the implementation of partnership awards between institutions serving underserved communities and populations and other institutions with extensive alcohol research programs, including NIAAA-funded alcohol research centers and consortia. For the purpose of this FOA, the term Institutions that serve Underserved Communities and Populations (IUCP) will refer to academic or other organizations serving scientifically and medically underserved communities and populations, and Alcohol Research Centers (ARC) will refer to institutions with extensive alcohol research programs including, but not limited to, NIAAA-funded alcohol research centers. This FOA is designed to facilitate planning and implementation of collaborative partnerships between IUCP and ARC to enhance the development of a diverse biomedical workforce (e.g., African Americans, Asians, Hispanics, Native Americans, Alaska Natives, Native Hawaiians, Pacific Islanders). Through productive partnership with ARC, this FOA aims to build and promote alcohol research expertise and to develop alcohol research infrastructure and capacity at IUCP. Institutions serving diverse and disadvantaged communities with a documented historical mission to educate students from nationally underrepresented groups are particularly encouraged to consider applying for this opportunity, because these institutions historically have trained professionals from diverse backgrounds who provide health care to underserved populations and are uniquely positioned to engage these populations in research and in the translation of research advances into culturally appropriate, measurable and sustained improvements in health outcomes
Funding Opportunity PAR-20-241 from the NIH Guide for Grants and Contracts. This funding opportunity announcement aims to support research that employs innovative scalable technologies to inventory, register and profile the cellular ensembles and/or cell-types that produce and/or respond to opioids. Emphasis is on approaches that enable high-throughput single-cell resolution mapping, anatomical characterization and/or molecular profiling of cells identified as primary sources of, or pharmacological targets of, opioids in the brain and/or whose changes in activity associate with opioid-related behaviors in rodents.
Notice NOT-MH-20-063 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-20-242 from the NIH Guide for Grants and Contracts. The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.